USPTO serial 79306727
UPATCH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 12, 2022
- Examiner
- HARMON, RAYMOND E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with UPATCH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jorge Arcinega
Jorge Arcinega Loeb & Loeb LLPSuite 220010100 Santa Monica Blvd.Los Angeles, CA 90067Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable pharmaceutical preparations that treat diseases that need swift medication delivery through the skin, namely, for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, hepatological, ophthalmic, respiratory, neurological, hormonal, gastrointestinal, dermatological and immube system related diseases and disorders, for use in blood glucose monitoring and for administering insulin, for treatment of scars, acne, depigmentation and alopecia, for migraine treatment preparations and for contraceptive preparations; medical applicators in the nature of injection devices sold with pharmaceutical preparations that treat diseases that need swift medication delivery through the skin, namely, for treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, hepatological, ophthalmic, respiratory, neurological, hormonal, gastrointestinal, dermatological and immube system related diseases and disorders, for use in blood glucose monitoring and for administering insulin, for treatment of scars, acne, depigmentation and alopecia, for migraine treatment preparations and for contraceptive preparations | ACTIVE | — |
| 010 | Medical devices and instruments, namely, injection devices for introducing pharmaceutical preparations into the human body; medical fluid injectors for administering medication through the skin, sold empty; injection instruments without needles; needles for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by uPRAX Microsolutions B.V.
- Other trademarks owned by uPRAX Microsolutions B.V.
- Other trademarks owned by uPRAX Microsolutions B.V.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named UPATCH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 26, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 26, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 12, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 12, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 22, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 5, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 21, 2021 | ALIE | ASSIGNED TO LIE | — |
| Dec 21, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 8, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 8, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 26, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 25, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 27, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |